• Corpus ID: 11803214

Coagulation profile in diabetes and its association with diabetic microvascular complications.

@article{Madan2010CoagulationPI,
  title={Coagulation profile in diabetes and its association with diabetic microvascular complications.},
  author={Ritu Madan and Bhuvanesh Gupt and Sumita Saluja and Uc Kansra and B K Tripathi and Brahm Prakash Guliani},
  journal={The Journal of the Association of Physicians of India},
  year={2010},
  volume={58},
  pages={
          481-4
        }
}
OBJECTIVES To investigate the haemostatic parameters and to assesss their relationship with microvascular complications in type 2 diabetes mellitus. MATERIALS AND METHODS Coagulation and fibrinolysis parameters were measured in 60 type 2 diabetic patients (M:F 1:1) with (n=40) and without (n=20) diabetic microvascular complications and in 30 nondiabetic healthy subjects (M:F 1:1). RESULTS The mean age of diabetic patients and healthy controls was 56.9 +/- 8.78 and 53.2 +/- 7.58 respectively… 

Tables from this paper

Clinical Significance of Hemostatic Parameters in the Prediction for Type 2 Diabetes Mellitus and Diabetic Nephropathy
TLDR
It is suggested that hemostatic parameters have a low predicting value for T2DM, whereas fibrinogen is a powerful predictor for DN.
Correlation of Fibrinogen and HsCRP with Microvascular Complications of Type 2 Diabetes Mellitus.
TLDR
Fibrinogen contributes to procoagulant state observed in diabetes, which leads to vascular complications and microvascular complications of diabetes, and microalbuminuria is the best predictor of fibr inogen levels in T2DM.
Coagulation factors IX and XI activities are significantly enhanced in type 2 diabetic patients
TLDR
Procoagulant state in DM2 as evidenced by enhanced activation of coagulation factors IX and XI and elevated fibrinogen concentration, may contribute to the increased risk of thrombosis and vascular complications inDM2 patients.
EFFECT OF DIABETES MELLITUS TYPE II ON ACTIVATED PARTIAL THROMBOPLASTIN
TLDR
It may be concluded that shorted APTT confirms that T2DM is a hyper-coagulable state due to which there is increased risk of thrombotic events.
COMPARISON OF PROTHROMBIN TIME AND ACTIVATED PARTIAL THROMBOPLASTIN TIME BETWEEN PATIENTS WITH DIABETES MELLITUS AND DIABETICS WITH HYPERTENSION
TLDR
This study showed Prolonged PT and APTT in diabetes mellitus with hypertension, which are the indications of altered activity or absence or decreased levels of clotting factors of intrinsic & extrinsic coagulation pathways respectively.
Inflammation, Haemostatic Disturbance, and Obesity: Possible Link to Pathogenesis of Diabetic Retinopathy in Type 2 Diabetes
TLDR
Logistic regression analyses showed that diabetes duration and prolonged poor glycemic control are the main predictors of retinopathy in patients with type 2 diabetes.
Serum fibrinogen level in type 2 diabetes mellitus patients
TLDR
The serum fibrinogen level in patients of Type 2 diabetes and correlate it with parameters like glycemic control (HbA1C), duration of diabetes mellitus, complications and pharmacotherapy is estimated to be higher in overweight patients as compared to normal weight patient in all groups.
Hemostatic state of children with type 1 diabetes
TLDR
Elevated levels of fibrinogen, PAI-1, and von Willebrand factor antigen were found in the pediatric and adolescent population with type 1 diabetes mellitus, which suggests a prothrombotic state.
...
...

References

SHOWING 1-10 OF 27 REFERENCES
Coagulation and Fibrinolysis Parameters in Type 2 Diabetic Patients with and without Diabetic Vascular Complications
TLDR
Patients with type 2 diabetes mellitus had a hypercoagulable state and hypofibrinolysis, thereby indicating that activation of coagulation with a reduced fibrinoallytic activity may contribute to the increased risk of vascular disease in type 2 diabetic patients.
Hypercoagulation in diabetes mellitus.
  • N. AcangF. Jalil
  • Medicine
    The Southeast Asian journal of tropical medicine and public health
  • 1993
TLDR
There was a significantly high fibrinogen and short PT and APTT in diabetic patients, especially those who suffered from diabetes for a long time and followed by chronic complications.
Diabetes, a hypercoagulable state? Hemostatic variables in newly diagnosed type 2 diabetic patients.
TLDR
Findings support the concept that diabetes can be associated with a hypercoagulable state, which is not necessarily dependent on the presence of overt vascular disease, or correlated with the degree of chronic hyperglycaemia (HbA1c levels).
Free Radical Activity and Hemostatic Factors in NIDDM Patients With and Without Microalbuminuria
TLDR
This study suggests that there is an increase in free radical activity and abnormalities in hemostatic variables favoring a hypercoagulable state in NIDDM, especially in those with microalbuminuria.
Thrombomodulin and induced tissue factor expression on monocytes as markers of diabetic microangiopathy: A prospective study on hemostasis and lipoproteins in insulin‐dependent diabetes mellitus
TLDR
In patients with insulin‐dependent diabetes mellitus elevated thrombin and fibrin generation reflects a hypercoagulable state but clinically detectable microangiopathy seems related to endothelial cell injury markers and to increased induced tissue factor expression on monocytes.
Contact phase of blood coagulation in diabetes mellitus
TLDR
It was found that the kallicreinprekallicreIn system was activated in diabetic patients and that such activation could probably be secondary to lesions of the vascular endothelium present in long‐term diabetics, and no correlation was found between glycaemia and activity levels of this system.
Platelet and coagulation factors in proliferative diabetic retinopathy.
TLDR
Changes in platelet and coagulation function may be secondary to the development of microvascular disease and their role in the pathogenesis of retinopathy remains uncertain.
Effect of insulin therapy on coagulation and platelet function in type II (non-insulin-dependent) diabetes mellitus.
TLDR
Tests of coagulation and platelet function performed while receiving high-dose sulphonylurea therapy and at 1 and 3 months following their conversion to insulin suggest the introduction of an insulin regimen that improves glycaemic control might lead to a reversal of the 'hypercoagulable state' found in type II diabetes.
Association between plasma thrombin-activatable fibrinolysis inhibitor levels and activated protein C in normotensive type 2 diabetic patients.
TLDR
The plasma levels of TAFI are reported to be increased in diabetic patients and it may play an important role in the mechanism of hypofibrinolysis observed in these patients, and the thrombin-thrombmodulin complex on the plasma membrane of endothelium is investigated.
...
...